The Filter Loop Technique as a Method of Measuring Platelet Aggregation in the Flowing Blood of the Rat; the Inhibitory Activity of 5-oxo-l-cyclopentene-l-heptanoic Acid (AY-16,804) on Platelet Aggregation

Christopher R. Muirhead

doi:10.1055/s-0038-1649110

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1973; 30(01): 138-147
DOI: 10.1055/s-0038-1649110

Original Article

Schattauer GmbH

The Filter Loop Technique as a Method of Measuring Platelet Aggregation in the Flowing Blood of the Rat; the Inhibitory Activity of 5-oxo-l-cyclopentene-l-heptanoic Acid (AY-16,804) on Platelet Aggregation^[*]

Christopher R. Muirhead Ph.D.

¹Department of Pharmacology, Ay erst Research Laboratories, P. O. Box 6115, Montreal 101, Quebec, Canada

› Author Affiliations

Abstract

Summary

The filter loop technique which measures platelet aggregation in vivo in the flowing-blood of the rat was compared to the optical density technique of Born which is carried out in vitro with platelet rich plasma. Using these two experimental models the effect on platelet aggregation of three known inhibitors sulfinpyrazone, dipyridamole and prostaglandin E₁, and a novel compound 5-oxo-l-cyclopentene-l-heptanoic acid (AY-16, 804) was determined.

The effects on platelet aggregation of the known inhibitors were consistent with information in the literature. Prostaglandin E₁ was the most potent inhibitor in both techniques; sulfinpyrazone inhibited aggregation in both models but was less potent than prostaglandin E₁. AY-16, 804 exhibited activity in vitro and in vivo similar to that of sulfinpyrazone. Dipyridamole did not inhibit platelet aggregation in vivo and did not inhibit aggregation in vitro in concentrations at which it remained soluble.

The filter loop technique is a suitable model for measuring platelet aggregation in the flowing blood of the rat. It is a relatively simple method of determining aggregation and easily adapted to other species.

Full Text

References

References
1 Bagli J. F, Bogri T, Deghenghi R, and Wiesner K. 1966; Prostaglandins I. Total synthesis of 9β,15ξ-Dihydroxy prost-13-enoic acid. Tetrahedron Letters 5: 465.
2 Born G. V. R. 1962; Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature (London) 194: 927.
3 Born G. V. R, and Cross M. J. 1963; Effect of adenosine diphosphate on the concentration of platelets in circulating blood. Nature (London) 197: 974.
4 Brinkhous K. M, Leroy E. C, Cornell W. P, Brown R. C, Hazlehurst J. L, and Vennart G. P. 1958; Macroscopic studies on platelet agglutination; nature of thrombocyte agglutinating activity in plasma. Proceedings of the Society for Experimental Biology and Medicine 98: 379.
5 Bunag R. D, Douglas C. R, Imai S, and Berne R. M. 1964; Influence of a pyrimidopyrimidine derivative on deamination of adenosine by blood. Circulation Research 15: 83.
6 Chandler A. B. 1958; In vitro thrombotic coagulation of the blood. A method for producing a thrombus. Laboratory Investigation 7: 110.
7 Davey M. G, and Lander H. 1964; Effect of adenosine diphosphate on circulating platelets in man. Nature (London) 201: 1037.
8 Emmons P. R, Harrison M. J. G, Honour A. J, and Mitchell J. R. A. 1965; Effect of pyrimidopyrimidine derivative on thrombus formation in the rabbit. Nature (London) 208: 255.
9 Emmons P. R, Hampton J. R, Honour M. J. G, and Mitchell J. R. A. 1967; Effect of prostaglandin E₁ on platelet behavior in vitro and in vivo. British Medical Journal 2: 468.
10 Heslinga L. M, Vangoekom M, and Vandorp D. A. 1968; Preparation and diastereoisome-rism of four substituted epoxycyclopentanones. Recueil des Travaux Chimiques des Pay Bas 87: 1421.
11 Honour A. J, and Mitchell J. R. A. 1964; Platelet clumping in injured vessels. British Journal of Experimental Pathology 45: 75.
12 Hornstra G. 1970; a A method for the determination of thrombocyte aggregation in circulating rat blood. Experientia 26: 111.
13 Hornstra G. 1970; b Method to determine the degree of ADP-induced platelet aggregation in circulating rat blood (“filter loop technique”). British Journal of Haematology 19: 321.
14 Kloeze J. 1967 Influence of prostaglandins on platelet adhesiveness and platelet aggregation. In: Bergstrom S, and Samuelsson B. (eds.) Interscience. Proceedings of the Second Nobel Symposium, Stockholm, June 1966.
15 Mustard J. F, Rowsell H. C, Lutz F, Hegardt B, and Murphy E. A. 1968; The effect of adenine nucleotides on thrombus formation, platelet count and blood coagulation. Experimental and Molecular Pathology 5: 43.
16 O’Brien J. R. 1962; Platelet aggregation II. Some results from a new method of study. Journal of Clinical Pathology (London) 15: 452.
17 Sullivan J. M, Harken D. E, and Gorlin R. 1968; Pharmacologic control of thromboembolic complications of cardiac valve replacement. New England Journal of Medicine 279: 576.
18 Swank R. L, Roth J. G, and Jansen J. 1964; Screen filtration pressure method and adhesiveness and aggregation of blood cells. Journal of Applied Physiology 19: 340.
19 Weily H. S, and Genton E. 1970; Altered platelet function in patients with prosthetic mitral valves: Effects of sulfinpyrazone therapy. American Journal of Cardiology 26: 668.

The Filter Loop Technique as a Method of Measuring Platelet Aggregation in the Flowing Blood of the Rat; the Inhibitory Activity of 5-oxo-l-cyclopentene-l-heptanoic Acid (AY-16,804) on Platelet Aggregation[*]

The Filter Loop Technique as a Method of Measuring Platelet Aggregation in the Flowing Blood of the Rat; the Inhibitory Activity of 5-oxo-l-cyclopentene-l-heptanoic Acid (AY-16,804) on Platelet Aggregation^[*]